Satellite Symposia

Satellite Symposia

Timetable

Wednesday, 24 October 2018

Company Name FromToLocation
Shire 15:1516:45Auditorium VI

 

Thursday, 25 October 2018

Company Name FromToLocation
CSL Behring12:2013:50Auditorium VI

 

Friday, 26 October 2018

Company Name FromToLocation
Octapharma     12:2013:50Auditorium VI

 

Symposia Programmes


Wednesday, 24 OCTOBER 2018

LIFELONG INDIVIDUALISED CARE IN PID: NOVEL APPROACHES FOR DIAGNOSIS AND TREATMENT


SYMPOSIUM IS ORGANISED AND SUPPORTED BY Shire.png

Wednesday, 24 October, 15:15-16:45, Auditorium VI

BEYOND NEWBORN SCREENING: ADVANCES IN DIAGNOSIS AND TREATMENT FROM BIRTH TO CHILDHOOD
Pere Soler-Palacín (Spain)

AUTOIMMUNITY AND PID AND ITS IMPLICATIONS FOR INDIVIDUALISED CARE IN ADULTS
Klaus Warnatz (Germany)

PID IN THE ELDERLY: LATE STAGE COMPLICATIONS, FROM DISEASE OR TREATMENT?
Virgil Dalm (Netherlands)

QUESTIONS AND ANSWERS
All 


THURSDAY, 25 OCTOBER 2018

CURRENT AND EMERGING CAUSES OF SECONDARY IMMUNODEFICIENCY: A CROSS-SPECIALTY APPROACH 

SYMPOSIUM IS ORGANISED AND SUPPORTED BY CSL.png

Thursday, 25 October, 12:20-13:50, Auditorium VI

Chair:  Stephen Jolles (UK)          


12:20–12:25  INTRODUCTION
                        Stephen Jolles (UK)

12:25–12:45  WHEN B CELLS DON'T RECOVER – IATROGENIC CAUSES OF SECONDARY ANTIBODY DEFICIENCIES
Klaus Warnatz (Germany)

12:45–13:05  FAILURE TO RECONSTITUTE: PERSISTENT ANTIBODY DEFICIENCY AFTER BONE MARROW TRANSPLANTATION AND CAR-T CELL THERAPY
Troy R. Torgerson (USA)

13:05–13:10  SECONDARY ANTIBODY DEFICIENCY – ALL IN THE MIND?
                       
Stephen Jolles (UK)

13:10–13:15  B-CELL DEPLETION IN NEUROINFLAMMATORY DISEASE
                        Neil Robertson (UK)

13:15–13:50  EXPERT ROUNDTABLE DISCUSSION
                         
All
13:50               MEETING CLOSE
                         Stephen Jolles (UK) 


Friday, 26 OCTOBER 2018

ADVANCING THE MANAGEMENT OF SECONDARY IMMUNODEFICIENCIES

SYMPOSIUM IS ORGANISED AND SUPPORTED BY  OCT.png

Friday, 26 October, 12:20-13:50, Auditorium VI

Chairs:  Silvia Sánchez-Ramón (Spain)
               Carmen Scheibenbogen (Germany)              

12:20–12:25   WELCOME AND INTRODUCTION
Silvia Sánchez-Ramón (Spain)

12:25–12:45   SECONDARY IMMUNODEFICIENCY IN HEMATOLOGICAL MALIGNANCIES
Il-Kang Na (Germany)

12:45–13:05   IgG REPLACEMENT THERAPY IN HEMATOLOGICAL MALIGNANCIES - AN INTERNATIONAL SURVEY
David Edgar (Ireland)

13:05–13:25   THE USE OF HUMAN POLYVALENT IMMUNOGLOBULINS IN SECONDARY IMMUNODEFICIENCIES ASSOCIATED WITH HEMATOLOGICAL MALIGNANCY IN FRANCE
Vincent Lévy (France)

13:25–13:50   EVIDENCE AND INDICATIONS FOR IgG REPLACEMENT IN SECONDARY IMMUNODEFICIENCIES
Carmen Scheibenbogen (Germany)


Keep Me Updated